Nasdaq GlobeNewswire

Sciaky Posts Record December with the Sale of Four EBAM® Metal 3D Printing Systems

Del

The EBAM systems will be used to 3D print titanium structures for aerospace applications, as well as to produce large parts for ground-based military vehicles, and warships

 

CHICAGO, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Sciaky, Inc., a subsidiary of Phillips Service Industries, Inc. (PSI) and leading provider of metal additive manufacturing (AM) solutions, announced today that it has posted record machine sales in the month of December with the sale of four state-of-the-art Electron Beam Additive Manufacturing (EBAM®) systems. The buyers will use the machines to 3D print titanium structures for aerospace applications, as well as to produce large parts for ground-based military vehicles, and warships. Three of the four machines will be the popular EBAM 110 model. The fourth machine will be an EBAM 150 model, which has a nominal part envelope of 146" (3708 mm) x 62" (1575 mm) x 62" (1575 mm), allowing the customer to 3D print the industry's largest metal parts in-house. All four systems will be delivered around mid-2018.    

"Sciaky is proud to deliver more best-in-class EBAM metal 3D printing systems to the marketplace, which will be leveraged in a wide range of land, sea, air and space applications," said Scott Phillips, President & CEO of Sciaky, Inc. "Now, more than ever, manufacturers are looking for ways to reduce time and cost associated with producing large, high-value parts, and Sciaky EBAM systems have a proven track record of helping manufacturers achieve these business-critical goals."

Bob Phillips, Sciaky's Vice President of Marketing, added, "January is shaping up to be another great month for EBAM machine sales, and there will be more exciting industry news coming from Sciaky in the near future."

As the most widely scalable, metal additive manufacturing solution in the industry (in terms of work envelope), Sciaky's EBAM systems produce parts ranging from 8 inches (203 mm) to 19 feet (5.79 meters) in length. EBAM is also the fastest deposition process in the metal additive manufacturing market, with gross deposition rates up to 20 lbs. (9.07 kg) of metal per hour. EBAM brings quality and control together with IRISS® - the Interlayer Real-time Imaging and Sensing System, which is the only real-time monitoring and control system in the metal 3D printing market that can sense and digitally self-adjust metal deposition with precision and repeatability. This innovative closed-loop control is the primary reason that Sciaky's EBAM 3D printing process delivers consistent part geometry, mechanical properties, microstructure, and metal chemistry, from the first part to the last.

For more information on Sciaky, visit www.sciaky.com. You can also follow Sciaky on TwitterFacebookGoogle+YouTube and LinkedIn.

About Sciaky, Inc.

Sciaky, Inc., a subsidiary of Phillips Service Industries, is a world leader in metal 3D printing solutions. Our exclusive Electron Beam Additive Manufacturing (EBAM®) process is the fastest, most cost-effective 3D printing process in the market for large-scale metal parts, allowing manufacturers to save significant time and money over traditional manufacturing and rapid prototyping processes. Sciaky also provides industry-leading electron beam (EB) and advanced arc welding systems, as well as the most robust EB job shop welding services in the world, for the aerospace, defense, automotive, healthcare and other manufacturing industries. Our welding equipment meets rigid military specifications to manufacture items such as airframes, landing gear, jet engines, guided missiles and vehicle parts.

About Phillips Service Industries, Inc.

Established in 1967, Phillips Service Industries, Inc. (PSI) is a privately held global manufacturing and services holding company, which oversees a diverse collection of innovative subsidiaries: Beaver Aerospace & Defense, Inc., Mountain Secure Systems, POWERTHRU, PSI Repair Services, Inc., PSI Semicon Services, and Sciaky, Inc. We serve a wide range of high-tech industries like aerospace, defense, automotive, alternative energy, healthcare, security and semiconductor. Our award-winning products and services help reduce costs and maximize efficiency for many Fortune 500 companies around the globe, as well as the U.S. Military. We push the boundaries of technology on critical programs like Homeland Security, Defense research and space exploration, delivering innovative solutions for land, sea, air and space. We're PSI: Always innovating. Everywhere.(TM)

 

CONTACT:
Jay Hollingsworth
Public Relations Director
Phillips Service Industries (PSI)
(734) 853-5211
jay.hollingsworth@psi-corp.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7ba945f2-ac88-4501-a9ad-ce96d53dc36a




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Phillips Service Industries, Inc. via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Nampala Project (Mali): Exploration Program Started in 2017 to be Double Based on Promising and Encouraging New Mineral Resource Estimate and Supported by Well-oriented Geology24.9.2018 14:30Pressemelding

QUÉBEC CITY, Quebec, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Robex Resources Inc. (« Robex » and/or « the Company ») (TSXV : RBX / FWB : RB4) is pleased to report to the market the integration of all its 2017-2018 drilling results in a new Mineral Resource estimate in accordance with National Instrument 43-101 and resumption of its exploration and drilling works on its Nampala gold project (Nampala and Mininko properties, Mali). 2017-2018 DRILLING AND NEW MINERAL RESOURCE ESTIMATE (MRE 2018) HIGHLIGHTS 1 Main highlights are: Indicated Mineral Resources totaling 242,000 ounces of gold (175,000 oz in saprolite type (oxides), 61,000 oz in transition zone and 6,000 oz in fresh rock (sulphides)), which corresponds to a total of 10,148,000 t at 0.74 g/t Au; Inferred Mineral Resources totaling 81,000 ounces of gold (61,000 oz in saprolite type (oxides), 16,000 oz in transition zone and 4,000 oz in fresh rock (sulphides)), which corresponds to a total of 3,429,000 t at 0.73 g/t Au; Impact positif 2

XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa24.9.2018 14:30Pressemelding

AUSTIN, Texas, Sept. 24, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that it had completed enrollment in the U.S. for its Phase 2, open label clinical study evaluating subcutaneous administration of bermekimab in patients with moderate to severe Hidradenitis Suppurativa (HS). Enrollment has exceeded the planned limit for the study in just over two months, significantly outpacing expectations. XBiotech plans to accept a limited number of additional patients in Europe prior to study completion. John Simard, Chairman & CEO of XBiotech, commented, “We are very pleased by the enrollment rate we have seen in this study. Patient availability has been well beyond what was predicted. I believe this speaks to the need for new treatment options for this debilitating disease. I want to thank all of the patients and clinical sites for their ongoing participation in this study.” The phase 2 study involves a 13-week treatment regimen. Two groups of patients are being treated

ILPA Publishes Diversity and Inclusion Resources for the Private Equity Industry24.9.2018 13:00Pressemelding

Expansion to the ILPA Standard DDQ and Guidance on Code of Conduct Seek to Advance D&I Efforts Across the Ecosystem WASHINGTON and TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- The Institutional Limited Partners Association (ILPA) today announced the publication of several resources developed to support the advancement of diversity and inclusion (D&I) within the private equity (PE) industry. These resources include an expansion to ILPA’s standard Due Diligence Questionnaire (DDQ) and guidance for developing organizational Codes of Conduct for general partners (GPs), limited partners (LPs) and fund portfolio companies. The work was completed over the course of 2018 by a cross section of ILPA members representing a global perspective. Steve Nelson, CEO of ILPA, reflected on the imperative for all industry players to contribute to the D&I effort in a positive manner: “ILPA believes that diversity and inclusion is a strength that all stakeholders within the private equity ecosystem should em

SolarWinds to Showcase Change Monitoring and Extended Azure Monitoring Capabilities Across Unified Infrastructure Management and SaaS solutions Portfolio at Microsoft Ignite 201824.9.2018 12:30Pressemelding

Highlights support for IT Professionals and DevOps teams operating on and across Microsoft on-premise environments, Microsoft Azure, and Office 365 AUSTIN, Texas, Sept. 24, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, today announced its participation at Microsoft Ignite® 2018, September 24-28, 2018, in Orlando, Florida. SolarWinds will demonstrate the latest updates to its unified infrastructure management portfolio, built on the SolarWinds® Orion® Platform, alongside its suite of SaaS-delivered products designed for DevOps teams. These portfolio enhancements are designed to deepen visibility across both cloud infrastructure and applications to simplify full-stack monitoring for DevOps and IT professionals. The company will also preview its upcoming Cost Calculator for Microsoft® Azure® free tool. “Optimizing performance across even the most complex environments can be accomplished,” said Christoph Pfister, executive vice p

Barefoot Networks Teams Up with Western Digital and Università della Svizzera italiana to Showcase In-Network Consensus for Use with Storage Class Memory and P424.9.2018 09:00Pressemelding

Barefoot Tofino™ Used in P4 Implementation for Low Latency Storage Class Memory Access is Presented at the P4 European Workshop CAMBRIDGE, United Kingdom, Sept. 24, 2018 (GLOBE NEWSWIRE) -- P4 European Workshop —At the P4 European Workshop (P4EU 2018), Barefoot Networks and researchers from Western Digital and Università della Svizzera italiana (USI), with support from Xilinx and STORDIS, will today present a new breakthrough for providing in-network high-performance fault tolerance for Storage Class Memory (SCM) access using the P4 programming language. The demonstration uses a P4 program implementation developed by Western Digital and USI using Barefoot’s 6.5Tb/s Tofino™ switch ASIC. Programmable forwarding plane technology is enabling network owners to create and deliver value by accelerating application performance. One of the ways this is achieved is by offloading network functions that are run on servers or appliances onto switches. In addition to performing all standard switch a

4D Announces Positive Data From Phase 1b Study of Thetanix in Paediatric Crohn's Diseases Patients and Publication of Studies Showing Strong Efficacy of Thetanix in Preclinical Models of IBD24.9.2018 08:00Pressemelding

LEEDS, United Kingdom, Sept. 24, 2018 (GLOBE NEWSWIRE) -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announces positive top-line results for its Phase 1b study of Thetanix in paediatric patients with Crohn’s disease. The study achieved its primary objective, demonstrating that Thetanix was well tolerated with a good safety profile. The randomised, double-blind, placebo-controlled study was conducted in two parts, with a single-dose phase and a multiple-dose phase and treated a total of 18 subjects aged 16-18 with Crohn’s disease. In the single-dose phase, eight subjects were given a single dose of either Thetanix or placebo. In the multiple-dose phase, 10 subjects were given either Thetanix or placebo twice daily for seven consecutive days. The Company also announces the publication of data demonstrating the efficacy of Thetanix in pre-clinical models of inflammatory bowel disease (IBD). The data, published in the journal

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom